Coefficient Giving

Reflections from the Effective Giving & Careers team. Earlier this year we ran our first open call for the effective careers side of our work — a request for proposals from organizations that help people move into high-impact careers. We’re excited to share the results: We’re awarding $13,075,301 in grants to 28 organizations via the Effective Giving & Careers Fund, and several other Coefficient Giving funds expect to fund up to 16 more.

Coefficient Giving’s Largest Grant Ever: $276 Million, Co-Funded With GiveWell, to the Against Malaria Foundation The combined $276 million grant — $212 million from Coefficient Giving and $64 million from GiveWell — will pay for bed nets in the Democratic Republic of the Congo, where malaria remains one of the leading causes of death for young children.

Coefficient Giving is scaling rapidly right now, both in terms of dollars moved and people hired. To give prospective hires a window into the parts of Coefficient that can be hard to see from the outside, we asked staff members from across the org to tell us about what surprised them most when they arrived. If what follows sounds like a place you’d want to work, we hope you’ll take a look at our open roles.

In 1800, Mali’s per capita GDP was roughly 5x smaller than Britain’s. Today it is roughly 25x smaller. The Industrial Revolution accelerated growth in the UK and the benefits of the new tech eventually reached the whole world. But the process has taken so long that, two centuries later, the gap is still 5x larger than it was before the new tech arrived.

It’s an exciting time to be on the communications team here at Coefficient Giving. In the last two years, Coefficient’s profile has grown significantly as we’ve launched major collaborative funds like the Lead Exposure Action Fund and the Abundance & Growth Fund and significantly scaled our grantmaking, including directing more than $1 billion in giving last year, the most in our history.

Seven months ago, we committed $175 million for 2026 to GiveWell’s recommendations, which we think represent the gold standard for evidence-backed, cost-effective global health giving. In partnership with Good Ventures, the foundation of Cari Tuna and Dustin Moskovitz, we’re now increasing that commitment to $1 billion for 2026. This $1 billion will nearly double the cumulative funding we have previously committed to GiveWell’s recommendations over the last decade.

About Caleb Before joining Coefficient Giving, Caleb was the co-founder and co-CEO of the Institute for Progress (IFP), a nonpartisan think tank dedicated to accelerating scientific, technological, and industrial progress. Caleb managed IFP’s work on metascience, high-skilled immigration, and AI. We were an early supporter of IFP and think they have an incredible track record of counterfactual policy impact across the areas in which they work.

Most nonprofits start with a founder who has a cause they care about. Ambitious Impact (AIM) tries to found nonprofits in reverse: its staff research the most cost-effective interventions, then recruit entrepreneurs to launch organizations around them. Since 2018, AIM’s flagship program — Charity Entrepreneurship (CE) — has helped founders create nonprofits focused on everything from farm animal welfare to lead poisoning to premature infant mortality.

Saad Bhamla, an engineer at Georgia Tech, has been at the forefront of frugal innovation, a movement that seeks to build cheaper versions of existing scientific tools, like the $1 hearing aid. His latest innovation could well be another consequential contribution to global public health: a Raman spectroscopy device that can detect tuberculosis, all for under $100.

Coefficient Giving Launches $200 Million Strep A Vaccine Fund Initiative aims to accelerate development of vaccines by multiple years for a disease that kills more than 600,000 people annually Fund has raised just over $140 million at launch with backing from multiple major donors SAN FRANCISCO – Today, Coefficient Giving announced the launch of the Strep A Vaccine Fund, a multi-donor initiative to accelerate the development of vaccines against Strep A, which kills more than 600,000 people...